Avantor, Inc. (NYSE:AVTR) Receives Consensus Rating of “Hold” from Brokerages

Shares of Avantor, Inc. (NYSE:AVTR) have been given an average recommendation of “Hold” by the eighteen ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $12.00.

A number of research analysts recently issued reports on AVTR shares. TD Cowen reiterated a “hold” rating on shares of Avantor in a report on Wednesday, July 15th. Wall Street Zen upgraded Avantor from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Evercore set a $10.50 price target on shares of Avantor in a report on Monday, July 6th. Wolfe Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 30th. Finally, Stifel Nicolaus boosted their target price on shares of Avantor from $8.00 to $15.00 and gave the company a “hold” rating in a report on Thursday, July 30th.

Avantor Price Performance

Avantor stock opened at $14.28 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78. Avantor has a 52 week low of $7.26 and a 52 week high of $15.93. The stock has a market capitalization of $9.66 billion, a P/E ratio of -16.99, a price-to-earnings-growth ratio of 10.91 and a beta of 0.89. The stock has a fifty day moving average of $11.72 and a 200-day moving average of $9.66.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same quarter last year, the business posted $0.24 earnings per share. The company’s quarterly revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, sell-side analysts expect that Avantor will post 0.81 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Avantor

Several large investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC lifted its stake in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after buying an additional 1,189 shares during the period. Private Trust Co. NA lifted its position in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares during the period. Strategic Wealth Investment Group LLC bought a new position in Avantor during the second quarter worth $32,000. Los Angeles Capital Management LLC acquired a new stake in Avantor in the fourth quarter worth $32,000. Finally, Osaic Holdings Inc. increased its stake in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.